142 related articles for article (PubMed ID: 28566601)
21. Long-term suppressive effect of octreotide on progression of metastatic gastrinoma with multiple endocrine neoplasia type 1: seven-year follow up.
Yamaguchi M; Yamada Y; Hosokawa Y; Iwamoto R; Tamba S; Ihara A; Yamamoto K; Hoshida Y; Matsuzawa Y
Intern Med; 2010; 49(15):1557-63. PubMed ID: 20686291
[TBL] [Abstract][Full Text] [Related]
22. Multiple Endocrine Neoplasia type 1.
Piecha G; Chudek J; Wiecek A
Eur J Intern Med; 2008 Mar; 19(2):99-103. PubMed ID: 18249304
[TBL] [Abstract][Full Text] [Related]
23. Pancreatectomy in multiple endocrine neoplasia type 1-related gastrinomas and pancreatic endocrine neoplasias.
Tonelli F; Fratini G; Nesi G; Tommasi MS; Batignani G; Falchetti A; Brandi ML
Ann Surg; 2006 Jul; 244(1):61-70. PubMed ID: 16794390
[TBL] [Abstract][Full Text] [Related]
24. [Treatment for pancreatic endocrine tumors with or without multiple endocrine neoplasia type 1].
Imamura M
Nihon Geka Gakkai Zasshi; 2005 Aug; 106(8):472-8. PubMed ID: 16119110
[TBL] [Abstract][Full Text] [Related]
25. [Hereditary neuroendocrine gastroenteropancreatic tumors and multiple endocrine neoplasia type 1. I. Diagnosis].
Scherübl H; Schaaf L; Raue F; Faiss S; Zeitz M
Dtsch Med Wochenschr; 2004 Mar; 129(12):630-3. PubMed ID: 15011133
[No Abstract] [Full Text] [Related]
26. Intravenous calcium injection test is a novel complementary procedure in differential diagnosis for gastrinoma.
Wada M; Komoto I; Doi R; Imamura M
World J Surg; 2002 Oct; 26(10):1291-6. PubMed ID: 12205549
[TBL] [Abstract][Full Text] [Related]
27. Novel mutation 928G>C of MEN1 gene in a familial multiple endocrine neoplasia type 1 case (MEN1) with co-existence of insulinoma and glucagonoma.
Chen X; Sun S; Wang C; Chen D; Chen H; Ran X
J Diabetes; 2015 May; 7(3):426-9. PubMed ID: 25047095
[No Abstract] [Full Text] [Related]
28. Parathyroid carcinoma in multiple endocrine neoplasia type 1 (MEN1) syndrome: two case reports of an unrecognised entity.
Agha A; Carpenter R; Bhattacharya S; Edmonson SJ; Carlsen E; Monson JP
J Endocrinol Invest; 2007 Feb; 30(2):145-9. PubMed ID: 17392605
[TBL] [Abstract][Full Text] [Related]
29. Natural History of MEN1 GEP-NET: Single-Center Experience After a Long Follow-Up.
Giudici F; Cavalli T; Giusti F; Gronchi G; Batignani G; Tonelli F; Brandi ML
World J Surg; 2017 Sep; 41(9):2312-2323. PubMed ID: 28429092
[TBL] [Abstract][Full Text] [Related]
30. Multiple endocrine neoplasia type 1 (MEN1): its manifestations and effect of genetic screening on clinical outcome.
Pieterman CR; Schreinemakers JM; Koppeschaar HP; Vriens MR; Rinkes IH; Zonnenberg BA; van der Luijt RB; Valk GD
Clin Endocrinol (Oxf); 2009 Apr; 70(4):575-81. PubMed ID: 18616711
[TBL] [Abstract][Full Text] [Related]
31. Multiple endocrine neoplasia type 1 associated with a new germline Men1 mutation in a family with atypical tumor phenotype.
Perakakis N; Flohr F; Kayser G; Thomusch O; Parsons L; Billmann F; von Dobschuetz E; Rondot S; Seufert J; Laubner K
Hormones (Athens); 2016; 15(1):113-7. PubMed ID: 26732163
[TBL] [Abstract][Full Text] [Related]
32. Reverse referral: from pathology to endocrinology.
Witchel SF; Ranganathan S; Kilpatrick M; Carty SE
Endocr Pathol; 2009; 20(1):78-83. PubMed ID: 19205629
[TBL] [Abstract][Full Text] [Related]
33. Multiple endocrine neoplasia type 1: clinical and genetic features of the hereditary endocrine neoplasias.
Marx SJ; Agarwal SK; Kester MB; Heppner C; Kim YS; Skarulis MC; James LA; Goldsmith PK; Saggar SK; Park SY; Spiegel AM; Burns AL; Debelenko LV; Zhuang Z; Lubensky IA; Liotta LA; Emmert-Buck MR; Guru SC; Manickam P; Crabtree J; Erdos MR; Collins FS; Chandrasekharappa SC
Recent Prog Horm Res; 1999; 54():397-438; discussion 438-9. PubMed ID: 10548885
[TBL] [Abstract][Full Text] [Related]
34. Diagnosis and treatment of multiple endocrine neoplasia type 1 (MEN1).
Gaztambide S; Vazquez F; Castaño L
Minerva Endocrinol; 2013 Mar; 38(1):17-28. PubMed ID: 23435440
[TBL] [Abstract][Full Text] [Related]
35. Novel 14 base-pair deletion of the MEN1 gene in a patient with recurrent primary hyperparathyroidism.
Katai M; Sakurai A; Uchino S; Minemura K; Hashizume K; Fukushima Y
Jpn J Clin Oncol; 2006 Jun; 36(6):395-7. PubMed ID: 16714299
[TBL] [Abstract][Full Text] [Related]
36. Multiple endocrine neoplasia type 1 in Brazil: MEN1 founding mutation, clinical features, and bone mineral density profile.
Lourenço DM; Toledo RA; Mackowiak II; Coutinho FL; Cavalcanti MG; Correia-Deur JE; Montenegro F; Siqueira SA; Margarido LC; Machado MC; Toledo SP
Eur J Endocrinol; 2008 Sep; 159(3):259-74. PubMed ID: 18524795
[TBL] [Abstract][Full Text] [Related]
37. A case of type 1 multiple endocrine neoplasia with esophageal stricture successfully treated with endoscopic balloon dilation and local steroid injection combined with surgical resection of gastrinomas.
Matsubayashi H; Kawata N; Kakushima N; Tanaka M; Takizawa K; Kiyozumi Y; Horiuchi Y; Sasaki K; Sugiura T; Uesaka K; Ono H
BMC Gastroenterol; 2017 Mar; 17(1):37. PubMed ID: 28270118
[TBL] [Abstract][Full Text] [Related]
38. Ovarian gastrinoma in multiple endocrine neoplasia type I: a case report.
Abboud P; Bart H; Mansour G; Pinteaux A; Birembaut P
Am J Obstet Gynecol; 2001 Jan; 184(2):237-8. PubMed ID: 11174512
[TBL] [Abstract][Full Text] [Related]
39. Gender-related differences in MEN1 lesion occurrence and diagnosis: a cohort study of 734 cases from the Groupe d'etude des Tumeurs Endocrines.
Goudet P; Bonithon-Kopp C; Murat A; Ruszniewski P; Niccoli P; Ménégaux F; Chabrier G; Borson-Chazot F; Tabarin A; Bouchard P; Cadiot G; Beckers A; Guilhem I; Chabre O; Caron P; Du Boullay H; Verges B; Cardot-Bauters C
Eur J Endocrinol; 2011 Jul; 165(1):97-105. PubMed ID: 21551167
[TBL] [Abstract][Full Text] [Related]
40. Concepts for screening and diagnostic follow-up in multiple endocrine neoplasia type 1 (MEN1).
Karges W; Schaaf L; Dralle H; Boehm BO
Exp Clin Endocrinol Diabetes; 2000; 108(5):334-40. PubMed ID: 10989951
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
